Fetal Pancreatic Circumference as a Predictor of Gestational Diabetes Mellitus During 75 g OGTT
- PMID: 40807035
- PMCID: PMC12347883
- DOI: 10.3390/jcm14155414
Fetal Pancreatic Circumference as a Predictor of Gestational Diabetes Mellitus During 75 g OGTT
Abstract
Objectives: The objective of this study was to investigate the relationship between the simultaneous 75 g Oral glucose tolerance test (OGTT), gestational diabetes mellitus (GDM), and fetal pancreatic circumference at 24-28 weeks of gestation. Methods: This prospective case-control study was conducted between September 2024 and February 2025 at our perinatology clinic, which provides tertiary health care services. The correlation between the 75 g OGTT, GDM, and pancreatic circumference was assessed by comparing fetal pancreatic circumference between the groups with and without GDM at the time of diagnosis. Results: A total of 130 pregnant patients were recruited for this` study, with 64 patients forming the GDM group and 66 patients forming the control group. Fetal pancreas circumference (7.0 cm vs. 6.4 cm, p < 0.001), fetal pancreas circumference percentile (88.5 vs. 52, p < 0.001), and the rate of fetal pancreas size >90th percentile (15.6% vs. 3%, p < 0.001) were significantly higher in the GDM group compared to the control group. Conclusions: Although our findings demonstrate a statistically significant correlation between fetal pancreatic circumference and GDM, diagnostic performance remains modest. Therefore, fetal pancreatic circumference should be interpreted as a supportive marker, such as family history, rather than a definitive marker for identifying individuals at risk for GDM.
Keywords: 75 g oral glucose tolerance test; fetal pancreas circumference; fetal pancreas circumference percentile; gestational diabetes mellitus.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
References
-
- Diabetes Canada Clinical Practice Guidelines Expert Committee. Feig D.S., Berger H., Donovan L., Godbout A., Kader T., Keely E., Sanghera R. Diabetes and Pregnancy. Can. J. Diabetes. 2018;42((Suppl. 1)):S255–S282. doi: 10.1016/j.jcjd.2017.10.038. Erratum in Can. J. Diabetes 2018, 42, 337. - DOI - PubMed
-
- HAPO Study Cooperative Research Group. Metzger B.E., Lowe L.P., Dyer A.R., Trimble E.R., Chaovarindr U., Coustan D.R., Hadden D.R., McCance D.R., Hod M., et al. Hyperglycemia and adverse pregnancy outcomes. N. Engl. J. Med. 2008;358:1991–2002. - PubMed
-
- Huhn E.A., Göbl C.S., Fischer T., Todesco Bernasconi M., Kreft M., Kunze M., Vogt D.R., Dölzlmüller E., Jaksch-Bogensperger H., Heldstab S., et al. Sensitivity, specificity, and diagnostic accuracy of WHO 2013 criteria for diagnosis of gestational diabetes mellitus in low risk early pregnancies: International, prospective, multicentre cohort study. BMJ Med. 2023;2:e000330. doi: 10.1136/bmjmed-2022-000330. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
